Skip to main content
. 2018 Jul 30;9(17):3006–3015. doi: 10.7150/jca.25956

Figure 7.

Figure 7

miR-124 inhibits the tumorigenesis of HCC in vivo. Mouse models were constructed through infected with LV-miR-124 or LV-miR-CON. The tumor size (A) growth curve (B) and tumor weight (C) were measured and calculated in two treatment groups. (D) The expression of BIRC3 and P65 were detected by immunohistochemistry (**p < 0.01).